Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM BSE: 507789
₹168.67
(0.01%)
Tue, 03 Mar 2026, 00:02 pm
Market Cap11.3B
PE Ratio27.54
Dividend1.48
Health Technology
Pharmaceuticals: Generic
24.5KJagsonpal Pharmaceuticals Analysis
dividend
- Dividends paid are thoroughly covered by earnings (14.2x coverage).
- Jagsonpal Pharmaceuticals's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- No dividend growth in 10 years.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Jagsonpal Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Jagsonpal Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Jagsonpal Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Jagsonpal Pharmaceuticals is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (688.2%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 23.3x debt.
- Jagsonpal Pharmaceuticals's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (36.1% vs 4.1% today).
- Jagsonpal Pharmaceuticals earns more interest than it pays, coverage of interest payments is not a concern.
- Jagsonpal Pharmaceuticals's level of debt (4.1%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The tenure for the Jagsonpal Pharmaceuticals board of directors is about average.
- Rajpal P.'s remuneration is lower than average for companies of similar size in India.
- Rajpal P.'s compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Jagsonpal Pharmaceuticals management team is over 5 years, this suggests they are a seasoned and experienced team.
misc
- Jagsonpal Pharmaceuticals is not covered by any analysts.
- Jagsonpal Pharmaceuticals has significant price volatility in the past 3 months.
past
- Jagsonpal Pharmaceuticals's 1-year earnings growth exceeds its 5-year average (212.6% vs 8.5%)
- Jagsonpal Pharmaceuticals's year on year earnings growth rate has been positive over the past 5 years.
- Jagsonpal Pharmaceuticals has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Jagsonpal Pharmaceuticals's earnings growth has exceeded the IN Pharmaceuticals industry average in the past year (212.6% vs 22.7%).
- Jagsonpal Pharmaceuticals used its assets less efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Jagsonpal Pharmaceuticals has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- Jagsonpal Pharmaceuticals's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Jagsonpal Pharmaceuticals's share price is below the future cash flow value, and at a substantial discount (> 40%).
- Jagsonpal Pharmaceuticals is good value based on assets compared to the IN Pharmaceuticals industry average.
- Jagsonpal Pharmaceuticals is good value based on earnings compared to the IN Pharmaceuticals industry average.
- Jagsonpal Pharmaceuticals is good value based on earnings compared to the India market.
- 507789 outperformed the Market in India which returned -14.5% over the past year.
- BSE:507789 is up 16.9% outperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- BSE:507789 is up 16.9% outperforming the market in India which returned 8% over the past month.
- 507789 underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800